Showing 1 - 20 results of 20 for search 'S. A. Tyulyandin', query time: 0.05s
Refine Results
-
1
COMBINATION CHEMOTHERAPY REGIMENS IN PANCREATIC CANCER by A. S. POPOVA, I. A. POKATAEV, S. A. TYULYANDIN
Published 2017-06-01
Article -
2
Metronomic chemotherapy regimens in oncology by M. Yu. Fedyanin, I. A. Pokataev, S. A. Tyulyandin
Published 2016-04-01
Article -
3
CHEMOTHERAPY BREAST CANCER MODERN VIEW ON THE PROBLEM by V. F. SEMIGLAZOV, V. A. GORBUNOVA, S. A. TYULYANDIN
Published 2017-06-01
Article -
4
Modern aspects of antiangiogenic therapy in ovarian cancer by A. A. Rumyantsev, I. A. Pokataev, S. A. Tyulyandin
Published 2018-11-01
Article -
5
Does asymptomatic primary tumor need to be removed in unresectable metastatic colon cancer? by M. Yu. Fedyanin, A. A. Tryakin, S. A. Tyulyandin
Published 2015-10-01
Article -
6
-
7
-
8
Prospects of therapeutic action on FGFR signaling pathway by M. Yu. Fedyanin, D. N. Khmelkova, T. S. Serebriyskaya, T. A. Nikolskaya, S. A. Tyulyandin
Published 2015-06-01
Article -
9
Some aspects of immunotherapy in colon cancer by M. Yu. Fedyanin, Kh. Kh.-M. El’snukaeva, A. A. Tryakin, S. A. Tyulyandin
Published 2018-05-01
Article -
10
-
11
Tamoxifen Molecular Targets Different From Estrogen Receptors by T. A. Bogush, E. A. Dudko, E. A. Bogush, B. E. Polotsky, S. A. Tyulyandin, M. I. Davydov
Published 2020-05-01
Article -
12
-
13
ERCC1 as a Marker of Ovarian Cancer Resistance to Platinum Drugs by T. A. Bogush, A. S. Popova, E. A. Dudko, E. A. Bogush, A. S. Tyulyandina, S. A. Tyulyandin, M. I. Davydov
Published 2020-05-01
Article -
14
-
15
The Quantitative Indices of ERCC1 Expression in Serous Ovarian Cancer Tissue and the Efficacy of First-Line Platinum-Based Chemotherapy by T. A. Bogush, M. B. Stenina, E. A. Bogush, V. T. Zarkua, S. A. Kalyuzhny, I. A. Mamichev, A. S. Tyulyandina, S. A. Tyulyandin
Published 2020-05-01
Article -
16
Olaparib maintenance therapy after frontline chemotherapy in patients with BRCA-mutated ovarian cancer: real-world results in expanded access program by A. A. Rumyantsev, A. S. Tyulyandina, I. A. Pokataev, E. R. Israelyan, M. Е. Abramov, H. N. Lud, S. A. Tyulyandin
Published 2022-06-01
Article -
17
-
18
-
19
Efficacy of first-line oxaliplatin-based chemotherapy regimens depending on the KRAS mutation status by M. Yu. Fedyanin, Kh. Kh.-M. El’snukaeva, I. A. Pokataev, A. A. Tryakin, A. A. Bulanov, O. V. Sekhina, D. A. Chekini, E. O. Ignatova, S. S. Gordeev, M. D. Budurova, Z. Mamedli, D. V. Podluzhnyy, N. A. Kozlov, S. A. Tyulyandin
Published 2018-05-01
Article -
20
Factors affecting the efficacy of gemcitabine and nab-paclitaxel (paclitaxel + albumin) combination in the Russian patient population: results of a multicenter retrospective study by I. A. Pokataev, M. A. Lyadova, M. Yu. Fedyanin, A. A. Tryakin, V. F. Chubenko, F. V. Moiseenko, L. A. Zagorskaya, M. L. Stepanova, A. V. Androsova, D. A. Nosov, N. V. Karpova, O. I. Kit, L. Yu. Vladimirova, I. L. Popova, A. V. Belonogov, D. M. Ponomarenko, D. Yu. Yukalchuk, V. E. Shikina, N. V. Ivanova, A. I. Khasanova, A. D. Kruglov, I. Yu. Stradaeva, A. S. Perepletova, V. M. Filippova, N. L. Buzova, O. V. Khavaneva, Kh. S. Musaeva, A. Yu. Goryainova, O. V. Romanchuk, I. Sh. Tespizhek, S. A. Tyulyandin
Published 2019-12-01
Article